Patients implanted with dual-chamber implantable cardioverter-defibrillators (ICDs) had higher rates of complications at one year than did patients who received single-chamber devices, with no apparent benefits in hospitalization or mortality. The results were published in the May 15 issue of the Journal of the American Medical Association.